Evaluation of human hepatocyte incubation as a new tool for metabolism study of androstenedione and norandrostenedione in a doping control perspective

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 780, Issue 1, 2002, Pages 145-153

  Lévesque, Jean François ^a   Gaudreault, Mireille ^a   Houle, Robert ^a   Chauret, Nathalie ^a  

^a MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

Author keywords

Androstenedione; Hepatocyte; Norandrostenedione; Steroids

Indexed keywords

BIOMARKERS; HYDROXYLATION; METABOLISM; METABOLITES; REDUCTION;

INCUBATIONS;

BIOMEDICAL ENGINEERING;

ANDROSTENEDIONE; ESTR 4 ENE 3,17 DIONE; NANDROLONE DERIVATIVE; TESTOSTERONE;

ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; DOPING; GAS CHROMATOGRAPHY; GLUCURONIDATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROXYLATION; IN VITRO STUDY; IN VIVO STUDY; KIDNEY METABOLISM; LIVER CELL; MASS SPECTROMETRY; METABOLITE; OXIDATION REDUCTION REACTION; PRECURSOR; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; SULFATION; URINALYSIS; CELL CULTURE; EVALUATION; MASS FRAGMENTOGRAPHY; METABOLISM;

ANDROSTENEDIONE; CELLS, CULTURED; DOPING IN SPORTS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HEPATOCYTES; HUMANS;

EID: 1842869157     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-0232(02)00444-0     Document Type: Article

References (26)

1. Comité International Olympique, IOC Medical Code and Explanatory Documents, 2000.
2. A. Noret, Le Dopage, Editions Vigot, Paris, 1981.
3. Ayotte C., Goudreault D., Charlebois A. J. Chromatogr. B. 687:1996;3.
4. De Cock K.J., Delbeke F.T., Van Eenoo P., Desmet N., Roels K., De Backer P. J. Pharm. Biomed. Anal. 25:2001;843.
5. Schanzer W., Horning S., Opfermann G., Donike M. J. Steroid Biochem. Mol. Biol. 57:1996;363.
6. Wrighton S.A., Vandenbranden M., Stevens J.C., Shipley L.A., Ring B.J., Rettie A.E., Cashman J.R. Drug Metab. Rev. 25:1993;453.
7. Rodrigues A.D. Biochem. Pharmacol. 48:1994;2147.
8. Ekins S., Maenpaa J., Wrighton S.A. Woolf T.F., Handbook of Drug Metabolism. 1999;363 Marcel Dekker, New York.
9. Clouet A.S., Le Bizec B., Boerlen F., Monteau F., André F. Analyst. 123:1998;2489.
10. Coldham N.G., Biancotto G., Montesissa C., Howells L.C., Sauer M.J. Analyst. 123:1998;2589.
11. Clouet-Dumas A.S., Le Bizec B., Le Pape M.A., Maume D., Monteau F., André F. J. Steroid Biochem. Mol. Biol. 74:2000;57.
12. Rendic S., Nolteernsting E., Schanzer W. J. Chromatogr. B. 735:1999;73.
13. J.-F. Lévesque, C. Ayotte in: W. Schanzer, H. Geyer, A. Gotzmann, U. Marek-Engelke (Eds.), Proceedings of the 17th Cologne Workshop on Dope Analysis, Cologne, March 1999, 2000, p. 169.
14. Uralets V.P., Gillette P.A. J. Anal. Toxicol. 23:1999;357.
15. D. Goudreault, P. Bhérer, J.-F. Lévesque, D. Poirier, C. Ayotte in: W. Schanzer, H. Geyer, A. Gotzmann, U. Marek-Engelke (Eds.), Proceedings of the 19th Cologne Workshop on Dope Analysis, Cologne, March 2001, 2002 (in press).
16. W. Schanzer, A. Breidbach, H. Geyer, C.V. Kuk, E. Nolteernsting, M. Thevis in: W. Schanzer, H. Geyer, A. Gotzmann, U. Marek-Engelke (Eds.), Proceedings of the 18th Cologne Workshop on Dope Analysis, Cologne, February 2000, 2001, p. 155.
17. Gordon Gibson G. Introduction To Drug Metabolism. 2001;Nelson Thornes, Cheltenham, UK.
18. Silva J.M., Day S.H., Nicoll-Griffith D.A. Chem. Biol. Interact. 121:1999;49.
19. Li A.P., Roque M.A., Beck D.J., Kaminski D.L. J. Tissue Cult. Methods. 14:1992;139.
20. Berry M.N., Edwards A.M., Barrit C.J. Isolated Hepatocytes Preparation, Properties and Applications. 1991;Elsevier Science, Amsterdam, Netherlands. p. 46.
21. W.J.J. Leunissen, Quantitative aspects of the determination of steroid profiles from urine by capillary gas chromatography, Ph.D. Thesis, Eindhoven, Netherlands, 1979.
22. J.-F. Lévesque, L'importance clinique de l'excrétion urinaire de stéroïdes sulfoconjugués lors de contrôle antidopage, Master Thesis, Pointe-Claire, Canada, 1998.
23. Sloan S., Harvey D.J., Vouros P. Org. Mass Spectrom. 5:1971;789.
24. Harvey D.J., Vouros P. Biomed. Mass Spectrom. 6:1979;135.
25. Grupe A., Spiteller G. Org. Mass Spectrom. 13:1978;448.
26. Schanzer W. Clin. Chem. 42:1996;1001.